Rankings
▼
Calendar
NUVL Q3 2024 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena
NUVL
Nuvalent, Inc.
$8B
Q3 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$76M
Net Income
-$84M
EPS (Diluted)
$-1.28
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$46M
Free Cash Flow
-$46M
Stock-Based Comp.
$15M
Balance Sheet
Total Assets
$1.2B
Total Liabilities
$68M
Stockholders' Equity
$1.1B
Cash & Equivalents
$369M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$76M
-$39M
-96.8%
Net Income
-$84M
-$34M
-150.7%
← FY 2024
All Quarters
Q4 2024 →